Somewhat Favorable Media Coverage Likely to Impact AmerisourceBergen Corp. (ABC) Share Price
Headlines about AmerisourceBergen Corp. (NYSE:ABC) have been trending somewhat positive this week, Alpha One Sentiment Analysis reports. The research group, a service of Accern, identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real time. Alpha One ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. AmerisourceBergen Corp. earned a coverage optimism score of 0.11 on Alpha One’s scale. Alpha One also assigned headlines about the company an impact score of 80 out of 100, meaning that recent news coverage is likely to have an impact on the stock’s share price in the immediate future.
Here are some of the headlines that may have effected Alpha One Sentiment’s analysis:
- AmerisourceBergen Corp. (ABC) Upgraded to “Buy” by BidaskClub (americanbankingnews.com)
- Head-To-Head Comparison: AmerisourceBergen Corp. (ABC) versus McKesson Corporation (MCK) (americanbankingnews.com)
- No one thought we’d reach the final: Sarfraz (cote-ivoire.com)
- AmerisourceBergen Reaches Analyst Target Price (nasdaq.com)
- American Capital Senior Floating Ltd (hoyentv.com)
AmerisourceBergen Corp. (ABC) traded down 2.01% on Friday, reaching $92.53. 1,880,554 shares of the company traded hands. The company has a market capitalization of $20.20 billion, a PE ratio of 17.96 and a beta of 0.93. AmerisourceBergen Corp. has a one year low of $68.38 and a one year high of $95.18. The stock’s 50 day moving average price is $89.44 and its 200 day moving average price is $86.27.
AmerisourceBergen Corp. (NYSE:ABC) last released its quarterly earnings data on Thursday, May 4th. The company reported $1.77 earnings per share for the quarter, beating analysts’ consensus estimates of $1.68 by $0.09. The business had revenue of $37.15 billion during the quarter, compared to analyst estimates of $38.07 billion. AmerisourceBergen Corp. had a net margin of 1.11% and a return on equity of 71.05%. AmerisourceBergen Corp.’s revenue was up 4.1% compared to the same quarter last year. During the same period last year, the business earned $1.68 EPS. On average, equities research analysts predict that AmerisourceBergen Corp. will post $5.87 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, June 5th. Shareholders of record on Monday, May 22nd were paid a dividend of $0.365 per share. The ex-dividend date was Thursday, May 18th. This represents a $1.46 dividend on an annualized basis and a yield of 1.58%. AmerisourceBergen Corp.’s dividend payout ratio is currently 28.24%.
Several equities research analysts have recently commented on the stock. Vetr raised shares of AmerisourceBergen Corp. from a “buy” rating to a “strong-buy” rating and set a $97.44 target price for the company in a research report on Tuesday, April 18th. Zacks Investment Research downgraded shares of AmerisourceBergen Corp. from a “buy” rating to a “hold” rating in a research report on Tuesday, February 21st. BidaskClub raised shares of AmerisourceBergen Corp. from a “hold” rating to a “buy” rating in a research report on Saturday. Mizuho boosted their target price on shares of AmerisourceBergen Corp. from $83.00 to $93.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 30th. Finally, Jefferies Group LLC assumed coverage on shares of AmerisourceBergen Corp. in a research report on Wednesday, May 17th. They set a “hold” rating and a $95.00 target price for the company. Seven equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $94.71.
TRADEMARK VIOLATION WARNING: “Somewhat Favorable Media Coverage Likely to Impact AmerisourceBergen Corp. (ABC) Share Price” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/06/17/amerisourcebergen-corp-abc-earning-somewhat-positive-press-coverage-analysis-shows-updated-updated.html.
In other news, Chairman Steven H. Collis sold 15,000 shares of the firm’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $81.98, for a total transaction of $1,229,700.00. Following the sale, the chairman now owns 253,876 shares of the company’s stock, valued at approximately $20,812,754.48. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Over the last 90 days, insiders have sold 45,000 shares of company stock valued at $3,930,900. 27.40% of the stock is owned by company insiders.
About AmerisourceBergen Corp.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Stock Ratings for AmerisourceBergen Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corp. and related stocks with our FREE daily email newsletter.